MedTrace Logo

The Inotrope Evaluation and Research Patient Registry

NCT03160846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2022-06-22

No results posted yet for this study

Summary

The INTERPRET Inotrope Evaluation and Research Patient Registry is a longitudinal, observational study designed to look at the demographics and outcomes of heart failure patients on inotropic therapy administered in the home or infusion suite setting. The data gathered in this registry will provide information on how a patient's quality of life and symptoms change over time while on inotrope therapy, and help healthcare providers to have a better understanding of the benefits and risks associated with bridge-to-treatment and palliative care.

Conditions

Interventions

DRUG

Inotrope

Home intravenous infusion of Dobutamine, Dopamine, or Milrinone

Sponsors & Collaborators

Principal Investigators

  • Erica Blanchard, PharmD · Coram/CVS specialty infusion

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-25
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03160846 on ClinicalTrials.gov